Myelin Repair Foundation: Accelerating Drug Discovery Through Collaboration Case Solution & Answer

Home » Case Study Analysis Solutions » Myelin Repair Foundation: Accelerating Drug Discovery Through Collaboration

This Case is about RESEARCH & DEVELOPMENT, RISK MANAGEMENT, STRATEGIC PLANNING

PUBLICATION DATE: March 01, 2010 PRODUCT #: 610074-HCC-ENG

To optimize their efficiency, color cases ought to be printed in color.This case provides the Myelin Repair Foundation’s sped up research study collaboration design for drug discovery.

Myelin Repair Foundation Accelerating Drug Discovery Through Collaboration Case Solution

It highlights the difficulties of constructing a multi-institutional and multi-disciplinary research study collaboration that is trying to develop a treatment for numerous sclerosis based upon an unique clinical method.

The case offers information on how standards of scholastic research study and copyright needed to be upgraded to make it possible for collaboration. The present issue dealing with the CEO and COO of the foundation associates with setting tactical concerns for research study so that a treatment for MS can be prepared in the next 10 years. The tactical options have to represent the intricacies of drug discovery, the unpredictability of business partners’ interest in the healing technique and the constricted donor-based fundraising environment.